MedTrace Logo

a Predictive Scheme for Poor Responders in IVF Cycles

NCT02351193 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 928

Last updated 2015-02-02

No results posted yet for this study

Summary

While practicing the different assisted reproductive techniques, the investigators are faced daily by the problem of poor responder females, and the debate about predicting its results based on the outcome of the different ORTs used. Due to the cost of AMH as an indicator for ovarian response, the need to re-assess its role was essential in our community, which led us to conduct this prospective multi-center IVF study.

Conditions

Interventions

OTHER

transvaginal Ultrasound

Sponsors & Collaborators

  • Dina Mohamed Refaat Dakhly

    lead OTHER

Principal Investigators

  • Dina MR Dakhly, MD · Cairo University

Eligibility

Min Age
20 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2013-12-31
Completion
2013-12-31

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02351193 on ClinicalTrials.gov